key: cord-1021052-i0b6d9px
authors: Hyland, Philip; Vallières, Frédérique; Shevlin, Mark; Bentall, Richard; McKay, Ryan; Hartman, Todd K.; McBride, Orla; Murphy, Jamie
title: Resistance to COVID-19 vaccination has increased in Ireland and the UK during the pandemic
date: 2021-04-27
journal: Public Health
DOI: 10.1016/j.puhe.2021.04.009
sha: 957f6668aa6e8c691188646c2a72cf35a6f61dfb
doc_id: 1021052
cord_uid: i0b6d9px

Objectives Hesitance and resistance to COVID-19 vaccination poses a serious challenge to achieving adequate vaccine uptake in the general population. Cross-sectional data from the early months of the pandemic indicates that approximately one-third of adults in multiple nations are hesitant or resistant to a vaccine for COVID-19. Using longitudinal data, we tracked changes in attitudes to COVID-19 vaccination during the pandemic. Study Design A quantitative, longitudinal design. Method Nationally representative samples of the adult general population of the Republic of Ireland (N = 1,041) and the United Kingdom (N = 2,025) were assessed for their attitudes towards COVID-19 vaccination at three points from March to August 2020. Results Statistically significant increases in resistance to COVID-19 vaccination were observed in Irish (from 9.5% to 18.1%) and British (6.2% to 10%) adults. Conclusion Resistance to vaccination has significantly increased in two European nations as the pandemic has progressed. Growing resistance to COVID-19 vaccination will pose a challenge to public health officials responsible for ensuring sufficient vaccine coverage.

 Resistance to COVID-19 vaccination significantly increased in Ireland and the UK from March to August 2020.

 COVID-19 vaccine resistance rose by 91% in Ireland and 61% in the UK.

 Increases in vaccine resistance in the UK was associated with a drop in vaccine hesitance.

 Increases in vaccine resistance in Ireland was associated with a drop in vaccine acceptance.

With an excess of 65 million confirmed cases across 190 countries globally, and over 1.5 million deaths, COVID-19 remains one of the most important global health challenges of our lifetime. 1 Recent announcements about the development of multiple, safe, and effective vaccines for COVID-19 offer a promising solution to this public health crisis. However, in addition to production and distribution challenges, a key challenge remains convincing a critical mass of the population to accept a COVID-19 vaccine.

In June 2020, 72% of people from 19 countries indicated that they would accept a COVID-19 vaccine, with rates as high as 89% in China and as low as 55% in Russia. 2 

Poll of the United States general population found that acceptance of a COVID-19 vaccine fell from 66% in July to 50% in September before increasing to 58% by the end of October. 3 While more longitudinal research is clearly required, early evidence suggests that people's attitudes towards a COVID-19 vaccine is fluctuating over time.

In March 2020, our research group initiated a longitudinal project that tracked nationally representative samples of adults from the Republic of Ireland and the United Kingdom (UK).

Asked if they would accept a hypothetical vaccine for COVID-19, approximately two-thirds of Irish (65%) and British (69%) adults responded 'yes'; about one-quarter responded 'maybe' (26% in Ireland and 25% in the UK); and the remainder responded 'no' (9% in Ireland and 6% in the UK). 4 Here we report changes in COVID-19 vaccine acceptance ('yes'), hesitance ('maybe'), and resistance ('no') in these samples during the first four months of the pandemic.

Identical sampling methods were used to collect data in Ireland and the UK. Participants were recruited from existing survey panels by Qualtrics using quota sampling to ensure the samples were representative of their populations by sex, age, regional, and income distributions. 4, 5 In Ireland, Wave 1 (N = 1,041) longitudinal data were collected from March J o u r n a l P r e -p r o o f Wave 3 (n = 534, recontact rate = 51%) from July 16 th to August 8 th . In the UK, Wave 1 (N = 2,025) longitudinal data were collected from March 23 rd to 28 th , Wave 2 (n = 1,406, recontact rate = 69%) from April 22 nd to May 1 st , and Wave 3 (n = 1,166, recontact rate = 58%) from July 9 th to August 9 th .

At each assessment, participants were asked, "If a new vaccine were to be developed that Moreover, the emergence and public distribution of actual vaccines for COVID-19 may shift public attitudes further, which presents an opportunity to assess how COVID-19 vaccine acceptance, hesitance, and resistance change in the context of an available vaccine; what predicts change in attitudes toward vaccination; and how well attitudes toward a hypothetical vaccine predict actual vaccine uptake. Timely, evidence-based answers to these questions will provide valuable public health information to health officials and policy makers to better inform social behaviour and communications strategies to increase the uptake of a COVID-19 vaccine. 

A global survey of potential acceptance of a COVID-19 vaccine

Americans Now Willing to Get COVID-19 Vaccine

Preparing for a COVID-19 vaccine: Identifying and psychologically profiling those who are vaccine hesitant or resistant in two general population samples

Monitoring the psychological, social, and economic impact of the COVID-19 pandemic in the population: Context, design and conduct of the longitudinal COVID-19 Psychological Research Consortium (C19PRC) Study

Missing data: our view of the state of the art

Best (but oft-forgotten) practices: missing data methods in randomized controlled nutrition trials

Mplus User's Guide

Note: 95% CI = confidence intervals; χ 2 = chi-square; all degrees of freedom = 1; * p < .05, ** p < .01, *** p < .001.

Highlights: Resistance to COVID-19 vaccination significantly increased in Ireland and the UK from March to August 2020. COVID-19 vaccine resistance rose by 91% in Ireland and 61% in the UK. Increases in vaccine resistance in the UK was associated with a drop in vaccine hesitance. Increases in vaccine resistance in Ireland was associated with a drop in vaccine acceptance.J o u r n a l P r e -p r o o f